Possibilities of the pharmacological correction of adaptive reactions of human organism in short-term moving from middle to high altitude]
Kundashev UK, Zurdinov AZ, Barchukov VG · 2014 · Eksperimental'naia i klinicheskaia farmakologiia 77(9):32-37. PMID 25365868
What does this source report?
A Metaprot–Ladasten combination was compared with hypoxen and placebo. The abstract reports earlier changes in exercise tolerance and metabolic and blood measures.
- Population and setting
- Volunteers moving from 1,670 m to 3,750 m after 15 days at middle altitude
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- No single-component arms are described, so the study cannot isolate contributions or establish synergy.
- Enrollment and allocation details require full-text review.
- Not a validated altitude-illness prevention strategy.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and abstract checked through Europe PMC / PubMed. Original methods and risk of bias not fully appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Kundashev UK, Zurdinov AZ, Barchukov VG. Possibilities of the pharmacological correction of adaptive reactions of human organism in short-term moving from middle to high altitude] Eksperimental'naia i klinicheskaia farmakologiia 77(9):32-37. PMID 25365868 2014.
Molekul research summary: https://molekul.io/research/acto-25365868. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Bemitil
A benzimidazole-derived actoprotector, also indexed as bemethyl and Metaprot. Research spans patient asthenia, occupational settings, neuromuscular and liver studies, metabolism and preclinical safety; these are research contexts, not established uses.
Bromantane
An adamantane-derived small molecule, also known as Ladasten. The expanded archive connects clinical asthenia studies, operator experiments and preclinical mechanisms, with model-specific limitations and safety findings.